| PMID | Title | Display |
|---|
| 2820171 | Animal carotenoids. 31. Structure elucidation of a sponge metabolite via mesylate elimination. |    |
|
| 1911741 | Kinetic characterization of phospholipase A2 modified by manoalogue. | |
|
| 18278856 | Strongylophorines: natural product inhibitors of hypoxia-inducible factor-1 transcriptional pathway. | |
|
| 18383454 | Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). | |
|
| 15544867 | Transdermal delivery from a lipid sponge phase--iontophoretic and passive transport in vitro of 5-aminolevulinic acid and its methyl ester. | |
|
| 19149592 | Marine sponges: potential sources of new antimicrobial drugs. | |
|
| 7666463 | Jasplakinolide's inhibition of the growth of prostate carcinoma cells in vitro with disruption of the actin cytoskeleton. | |
|
| 17354038 | Polybrominated hexahydroxanthene derivatives (PBHDs) and other halogenated natural products from the Mediterranean sponge Scalarispongia scalaris in marine biota. | |
|
| 1361808 | Analysis of clinical experience with a new twist lock connectology. | |
|
| 20066277 | Mirabilins revisited: polyketide alkaloids from a southern Australian marine sponge, Clathria sp. | |
|
